Navigation Links
Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor
Date:10/21/2010

LONDON, Oct. 21 /PRNewswire/ -- Shionogi-ViiV Healthcare LLC today announced the start of the Phase III clinical programme evaluating its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572). The Phase III clinical programme, which began this month, includes two studies (SPRING-2 and SAILING) that will evaluate '572 in both treatment-naive patients and treatment-experienced, but integrase-naive patients.

"Progression of one of our lead pipeline compounds into late stage development for use in treatment-naive and treatment-experienced patients is an important milestone for ViiV Healthcare in its first year and ultimately we hope for those living with HIV. We believe that this clearly demonstrates the benefit of our 100% focus on HIV and commitment to delivering new or improved treatment options," stated Dr. John Pottage, Chief Scientific and Medical Officer, ViiV Healthcare.

"We are pleased to see '572 progressing into Phase III clinical trials and are optimistic about its potential for HIV-infected patients," said Dr. Sapan Shah, President & CEO, Shionogi Inc. "As the only once-daily, unboosted integrase inhibitor in Phase III clinical development, '572 may help address certain treatment challenges that continue to face people living with HIV."

About the Phase III TrialsSPRING-2 Study Design (ING113086)SPRING-2 is a Phase III, randomized, blinded, active-controlled, multicenter, parallel group, non-inferiority study. The study will include approximately 788 HIV-1 infected treatment-naive patients.  The non-inferiority study will compare efficacy and safety outcomes of '572 and raltegravir (RAL); both treatment arms will be administered with investigator-selected dual nucleoside reverse transcriptase inhibitor therapy (either ABC/3TC or TDF/FTC).

The primary objective for SPRING-2 will be to demonstrate the antiviral activity of '572 50mg administered once-daily compared to RAL 400mg administere
'/>"/>

SOURCE Shionogi-ViiV Healthcare LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. HealthSport Enters Letter of Intent With CURE Pharmaceutical for Joint Development of Unique Pediatric Malaria Drug Product and Other Healthcare Related Products
2. McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in the United States and Puerto Rico
3. Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevadas Future
4. Janam Introduces Mobile Healthcare Product Line
5. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
6. Netsmart Technologies is First Behavioral Healthcare Software Provider to Pass Final Rule ARRA Certification Tests
7. Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference
8. Healthcare Providers Gain Control of Demand Channels With GHX Procurement Suite; 12 Percent Supply Spend Savings Achievable
9. ADVENTRX to Participate in Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13
10. Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya
11. Aging of America: Demographics of Demand and Profits in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and BOSTON , May 24, 2013 ... company, is pleased to announce that it has engaged Mr ... Company,s business development capabilities in Japan and ... years of experience in business development, licensing and alliance management in ... Pharma ( Japan ), Nippon Roche and Tanabe Seiyaku ...
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... 2013  A recently published clinical study conducted at ... , demonstrates that 3D mammography (breast tomosynthesis) significantly ... The study, "Implementation of Breast Tomosynthesis in ... by Stephen L. Rose , MD, ... American Journal of Roentgenology (AJR). The AJR is ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... /PRNewswire-iReach/ -- CoLucid Pharmaceuticals, Inc., a ... has raised $7.5 million of a planned $9.5 ... to support further late stage development of lasmiditan.  ... Associates, Care Capital, Pearl Street Venture Funds and ...
... DIEGO, Aug. 30, 2011 aTyr Pharma , ... to aTyr,s leadership team of Dr. Jeffrey Greve, as ... president, intellectual property. Drs. Greve and Cubitt will support ... on Physiocrine biology. Physiocrines are naturally occurring human proteins ...
Cached Medicine Technology:CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million 2aTyr Pharma Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology 2aTyr Pharma Expands Leadership Team to Advance New Breakthrough Medicines Based on Physiocrine Biology 3
(Date:5/24/2013)... 24 (HealthDay News) -- People with high levels of ... die of liver disease than those with lower levels, ... cadmium in urine is evidence of long-term exposure to ... and tobacco smoke, the Johns Hopkins researchers explained. ... cadmium directly causes liver disease but instead suggest an ...
(Date:5/24/2013)... Seattle, WA (PRWEB) May 24, 2013 ... consider when picking out a home security monitoring ... comparisons help make 6Webs.com the useful resource consumers prefer ... recently completed performing their evaluations of the leading wireless ... home security companies are rated on a number of ...
(Date:5/24/2013)... 2013 According to a May 15, 2013 ... Leads to Spikes in Plastic Surgery Requests,” a ... prevalence of facial plastic surgery and cosmetic improvements ... become keenly aware of the need to look good online ... Google and even Skype's video chat feature (Go to goo.gl/WO0PR). ...
(Date:5/24/2013)... LONG BEACH, CA (PRWEB) May 24, 2013 ... California's health care education community, proudly participated in festivities ... on April 19-21. The event provided the perfect backdrop ... and facilities at 236 E. 3rd Street, housed in ... the Arts Building. , ACC was an active exhibitor ...
(Date:5/24/2013)... May 24 (HealthDay News) -- The number of ... after spending time in an emergency room has ... research. The study, conducted by researchers at ... and Health Services in Washington, D.C., found that ... on average before being admitted to the ICU. ...
Breaking Medicine News(10 mins):Health News:High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study 2Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2
... IM), As part of an ongoing commitment to ... Portland, Ore. today announced its,investment in the world,s most ... be the first medical center on the West,Coast - ... to house IMRISneuro; a fully,integrated operating room that combines ...
... corporate infrastructure and provide ... tactical and strategic market advantages, HARRISBURG, Pa., ... a rapidly growing, national medical management,firm has promoted two ... Meghan Harris, MS, is KePRO,s new Vice,President, Informatics and ...
... (Nasdaq: ONXX ) today announced that it ... Conference on Thursday,May 1, at 8:00 a.m. Eastern ... of the presentation on our website at:, ... listeners log on 15 minutes early in order ...
... Protect Against Healthcare and Employment,Discrimination, BAYSIDE, ... Association, Inc. (TSA), hailed today,s vote in ... Genetic,Information Nondiscrimination Act (GINA), to ban genetic ... of Representatives passed GINA,in April 2007., ...
... Bliss Products Bring Blissful Comfort to Mothers-to-Be, SAN ... at the,end of the first trimester -- this is ... can really start enjoying their pregnancy.,However, those, who wish ... turn to magic. Mommy,s Bliss Morning Sickness Magic(TM) is,the ...
... and Quality of Care Rank as Top Factors in Choosing the Right ... ... the age of 50 expect an immediate family member to move into a ... of,65 expect the same for themselves, according to a new national survey of,American ...
Cached Medicine News:Health News:Providence St. Vincent bringing IMRISneuro, the world's most advanced surgical MRI to Portland, Oregon 2Health News:Providence St. Vincent bringing IMRISneuro, the world's most advanced surgical MRI to Portland, Oregon 3Health News:KePRO Appoints Two New IT Vice Presidents 2Health News:KePRO Appoints Two New IT Vice Presidents 3Health News:Tourette Syndrome Association Applauds the Passage of Genetic Information Nondiscrimination Act 2Health News:Morning Sickness Magic(TM) - An Effective Natural Approach to Morning Sickness 2Health News:New National Survey: 84% of Americans Over 50 Expect a Family Member to Move into an Assisted Living Community Within the Next 10 Years 2
Shandon Paraffin Block Cartons...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
Cardboard Block Filing Cabinet is an economical solution for block storage needs....
Shandon Carousel Cassette MicroWriter™ is a carousel-type cassette marking system....
Medicine Products: